SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-17-001272
Filing Date
2017-05-15
Accepted
2017-05-15 17:03:02
Documents
47
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT xenetic_10q-033117.htm 10-Q 247338
2 CERTIFICATION xenetic_10q-ex3101.htm EX-31.1 8686
3 CERTIFICATION xenetic_10q-ex3102.htm EX-31.2 8311
4 CERTIFICATION xenetic_10q-ex3201.htm EX-32.1 4623
  Complete submission text file 0001683168-17-001272.txt   1515175

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE xbio-20170331.xml EX-101.INS 169079
6 XBRL SCHEMA FILE xbio-20170331.xsd EX-101.SCH 22116
7 XBRL CALCULATION FILE xbio-20170331_cal.xml EX-101.CAL 35817
8 XBRL DEFINITION FILE xbio-20170331_def.xml EX-101.DEF 73431
9 XBRL LABEL FILE xbio-20170331_lab.xml EX-101.LAB 152328
10 XBRL PRESENTATION FILE xbio-20170331_pre.xml EX-101.PRE 123188
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37937 | Film No.: 17845508
SIC: 2834 Pharmaceutical Preparations